Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation‐effectiveness study

Cindy P. Garris, Maggie Czarnogorski, Marybeth Dalessandro, Ronald D'Amico, Toyin Nwafor, Will Williams, Deanna Merrill, YuanYuan Wang, Larissa Stassek, Michael B. Wohlfeiler, Gary I. Sinclair, Leandro A. Mena, Blair Thedinger, Jason A. Flamm, Paul Benson, William R. Spreen

Open source

DOI: 10.1002/jia2.26006
Published: 2022-09
Container: Journal of the International AIDS Society
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jia2.26006,
  title = {Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation‐effectiveness study},
  author = {Cindy P. Garris and Maggie Czarnogorski and Marybeth Dalessandro and Ronald D'Amico and Toyin Nwafor and Will Williams and Deanna Merrill and YuanYuan Wang and Larissa Stassek and Michael B. Wohlfeiler and Gary I. Sinclair and Leandro A. Mena and Blair Thedinger and Jason A. Flamm and Paul Benson and William R. Spreen},
  year = {2022},
  journal = {Journal of the International AIDS Society},
  doi = {10.1002/jia2.26006},
  url = {https://doi.org/10.1002/jia2.26006}
}

RIS

TY  - JOUR
TI  - Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation‐effectiveness study
AU  - Cindy P. Garris
AU  - Maggie Czarnogorski
AU  - Marybeth Dalessandro
AU  - Ronald D'Amico
AU  - Toyin Nwafor
AU  - Will Williams
AU  - Deanna Merrill
AU  - YuanYuan Wang
AU  - Larissa Stassek
AU  - Michael B. Wohlfeiler
AU  - Gary I. Sinclair
AU  - Leandro A. Mena
AU  - Blair Thedinger
AU  - Jason A. Flamm
AU  - Paul Benson
AU  - William R. Spreen
PY  - 2022
JO  - Journal of the International AIDS Society
DO  - 10.1002/jia2.26006
UR  - https://doi.org/10.1002/jia2.26006
ER  -

APA

Garris, C. P., Czarnogorski, M., Dalessandro, M., D'Amico, R., Nwafor, T., Williams, W., Merrill, D., Wang, Y., Stassek, L., Wohlfeiler, M. B., Sinclair, G. I., Mena, L. A., Thedinger, B., Flamm, J. A., Benson, P., & Spreen, W. R. (2022). Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation‐effectiveness study. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.26006

Source records

crossref · retrieved 2026-09-26T03:00:11.748Z